The Pain in Motion international research group, the department of Rehabilitation Medicine, Research School of CAPHRI, Maastricht University, and the Center of Expertise in Rehabilitation and Pain of Adelante would like to thank the following sponsors.
Kind regards, on behalf of the local organizing committee,
Prof. dr. R.J.E.M. Smeets
Professor Rehabilitation Medicine
Chair Local Organizing Committee Pain Science in Motion IV
Adelante is a care group with adult rehabilitation & occupational reintegration, pediatric rehabilitation, special education & housing and audiology & communication as core activities. Our motto is: get the best out of yourself. Together with our client, we do not focus on his or her limitations, but on the possibilities: what is still possible. We promise to get the best out of ourselves and our clients to push the boundaries of what is possible as far as possible.
CIR rehabilitation has been providing programs since 1988 that are aimed at helping people with chronic pain complaints to resume their lives. Everyone is unique and so is every treatment program. Our treatment method must suit you, instead of you having to suit the treatment method. CIR rehabilitation works with a permanent team of professionals around the client.
From the start, a multidisciplinary approach was used for people with complex chronic pain complaints based on a clear vision of the care to be provided; namely working from the biopsychosocial model. This working method has always remained the guiding principle of CIR over the years. For CIR, the starting point is to put the client back in control of his/her own life.
DEN Medical is the exclusive distributor in the Benelux of high-quality medical devices and systems. We strive for optimal service to our partners in healthcare, based on expertise and quality.
Buchrnhornen has been a concept name when it comes to foot and movement solutions for decades. The individual is central to everything we do. Every body is different and everyone has different wishes and needs. From this point of view, we offer support to anyone who has questions and/or complaints about their feet, walking and movement.
Improving lives and health outcomes.
Ipsen’s vision is to be a leading global mid-size biopharmaceutical company, with a focus on transformative medicines in three key therapeutic areas: oncology, rare disease and neuroscience. Under the overarching theme of Focus. Together.
For patients & society, Ipsen is focusing on four strategic priorities to accelerate our innovation and drive positive impact for patients, employees, shareholders and society—a strategy for the short and long term.
MYCB1 is a pharmaceutical and health technology company using Real-World Evidence in clinical and behavioural interventions with the final goal of optimising patients’ outcomes.
We focus on patients with clear unmet medical needs. Through ALETTA, our Real-World Data management platform and MYCB1 prescription-only products, we make it possible to provide novel pain treatments.
*ALETTA is free of charge for the patient and clinician. We believe in a future where the generation of high quality evidence happens not only in randomised controlled trials but in a real-world setting.
Changing lives for the better!
Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide.
Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain.